Skip to content

WESTPHARMA

Absorbed by LONCKE RENEE KBO/BCE: BE 0874.475.784
WESTPHARMA
Follow Report

Timeline

26 events since 2005
2022
Annual accounts 2021 filed PDFabbreviated format · 1 day late
2021
Merger: absorbed by General meeting of 30-10-20213 points ▸
  • General meeting, 30-10-2021
  • Accounting effect, 01-04-2021
  • Power of attorney, , mentioned 3 times in the deed
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

3 directors reappointed, and · General meeting of 08-10-20214 points ▸
  • General meeting, 08-10-2021
  • Director reappointment,
  • Director reappointment,
  • Director reappointment,

Open the deed in the Belgian Official Gazette

Merger proposal: to be absorbed by 3 points ▸
  • Capital, €61,500, 2,460 shares
  • Accounting effect, 01-04-2021
  • Capital, €18,600, 744 shares
  • The deed holds 9 more points.

Open the deed in the Belgian Official Gazette

Weakest financial year net €1,916 ▼91.4% The net result drops to €1,916, the lowest from 2007 to 2021.
Liquidity more than 7 times current ratio 69.63 The current ratio rises from 8.86 to 69.63. Short-term debt falls from €63,087 to €7,254.
Annual accounts 2020 filed PDFabbreviated format · 6 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 27 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 2 days before the deadline
2018
Registered office moved from Izegem to OostrozebekeNew registered office: Leegstraat 12b, 8780 Oostrozebeke · Previous registered office: Gentseheerweg 6 bus 1, 8870 Izegem · General meeting of 19-03-20182 points ▸
  • General meeting, 19-03-2018
  • Registered-office move, Leegstraat 12b, 8780 Oostrozebeke

Open the deed in the Belgian Official Gazette

Annual accounts 2017 filed PDFabbreviated format · 26 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · on the deadline day
2016
Annual accounts 2015 filed PDFabbreviated format · 20 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 1 day before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 5 days late
2013
Equity above €200,000 equity €230,204 ▲25.8% With a profit in every financial year since 2007, equity grows to €230,204.
Annual accounts 2012 filed PDFabbreviated format · 13 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 14 days late
2011
Highest result from 2007 to 2021 net €87,371 ▲457% The net result of €87,371 is the highest of those years.
Equity above €150,000 equity €152,639 ▲5.1% With a profit in every financial year since 2007, equity grows to €152,639.
Annual accounts 2010 filed PDFabbreviated format · 7 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 4 days late
2009
Annual accounts 2008 filed PDFabbreviated format · 11 days late
2008
Annual accounts 2007 filed PDFabbreviated format · 13 days late
2007
Annual accounts 2006 filed PDFabbreviated format · 2 days before the deadline
2005
Incorporation PDF10 publications in the Belgian Official Gazette, the last on 22-11-2021

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

In 2018 the registered office moved to Oostrozebeke.1 WESTPHARMA has filed 16 sets of annual accounts, the latest for financial year 2021.2 In 2021 the company was absorbed by merger into .3

  1. 1Belgian Official Gazette, 20-04-2018
  2. 2National Bank, annual accounts 2021
  3. 3Belgian Official Gazette, 22-11-2021

We would like to set cookies. That happens only with your consent. What we measure